GSA "Invites" Schedule Contractors To Examine Origin Of Offered Products
Client Alert | 1 min read | 02.15.06
On February 10, 2006, DOJ announced a $5.02 million settlement with Corporate Express, bringing to $28+ million the total obtained from defendants in U.S. ex rel Safini Office Products v. Office Depot et al . (D.D.C. No. 03-CV-003), a qui tam case involving allegations that the defendants had sold office products from non-designated countries on the GSA Schedule in violation of the Trade Agreements Act certification in the contracts. Also within the past week, in a development showing that all schedule contractors should be aware that TAA compliance has a become a major issue in GSA audits, GSA schedule contractors for office products began receiving a letter from GSA asking them to perform a self-assessment of the products they offered and to remove those items from countries that are not "designated countries" under the Trade Agreements Act, countries that would include such major sources of office and Information Technology products as China, India, Taiwan and Malaysia.
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
